Document is current
Any future updates will be listed below
-
Authors
Hawkins, Neil https://orcid.org/0000-0003-3199-221X
O’Brien, Paul https://orcid.org/0000-0002-6064-8023
Thompson, Juliette https://orcid.org/0000-0001-7646-9460
Anderson, Sarah-Jane
Manalastas, Eric https://orcid.org/0000-0002-6907-4302
Dupont-Benjamin, Laure https://orcid.org/0000-0001-7748-0768
Schroeder, Melanie
-
Funding
Funding for this research was provided by:
ViiV Healthcare
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 27 May 2025
First Online: 5 July 2025
Declarations
:
: Neil Hawkins, Juliette Thompson, and Eric Manalastas have received consulting fees from ViiV Healthcare. Paul O'Brien is an employee of ViiV Healthcare and may own stock in GSK. Sarah-Jane Anderson is an employee of GSK and owns stock in GSK and Haleon. Laure Dupont-Benjamin is an employee of ViiV Healthcare; owns stock in AbbVie, GSK, and Haleon; and has received consulting fees from the International Union Against Tuberculosis and Lung Disease. Melanie Schroeder is an employee of ViiV Healthcare; owns stock in GSK and Haleon.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
